Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
暂无分享,去创建一个
G. Galloway | W. Haning | Daniel L. Dickerson | A. Elkashef | Shou-Hua Li | J. Roache | T. Holmes | Tyson H Holmes | Ann L Anderson | Shou-Hua Li | Denka Markova | Nora Chiang | Roberta Kahn | Jan Campbell | Daniel L Dickerson | Gantt P Galloway | William Haning | John D Roache | Christopher Stock | Ahmed M Elkashef | R. Kahn | A. Anderson | D. Markova | N. Chiang | Jan Campbell | C. Stock | D. Dickerson
[1] Janet B W Williams,et al. A structured interview guide for the Hamilton Depression Rating Scale. , 1988, Archives of general psychiatry.
[2] R L Stout,et al. Ensuring balanced distribution of prognostic factors in treatment outcome research. , 1994, Journal of studies on alcohol. Supplement.
[3] W. Ling,et al. An intensive outpatient approach for cocaine abuse treatment. The Matrix model. , 1995, Journal of substance abuse treatment.
[4] T. Hergueta,et al. The mini international neuropsychiatric interview , 1998, European Psychiatry.
[5] D. Sheehan,et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.
[6] S. Faraone,et al. Training Raters to Assess Adult ADHD: Reliability of Ratings , 2005, Journal of attention disorders.
[7] N. Richard,et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled study , 2005, Biological Psychiatry.
[8] D. Ciraulo,et al. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. , 2005, Addiction.
[9] W. Ling,et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. , 2006, Addiction.
[10] Walter Ling,et al. Bupropion for the Treatment of Methamphetamine Dependence , 2008, Neuropsychopharmacology.
[11] George Bartzokis,et al. Abuse of Amphetamines and Structural Abnormalities in the Brain , 2008, Annals of the New York Academy of Sciences.
[12] R. Rawson,et al. The methamphetamine problem in the United States. , 2010, Annual review of public health.
[13] A. Weinstein,et al. Pharmacological approaches to methamphetamine dependence: a focused review. , 2010, British journal of clinical pharmacology.
[14] Nancy Brahm,et al. Treatments for Methamphetamine Abuse , 2011, Journal of pharmacy practice.
[15] Shou-Hua Li,et al. A Novel, Nonbinary Evaluation of Success and Failure Reveals Bupropion Efficacy Versus Methamphetamine Dependence: Reanalysis of a Multisite Trial , 2012, CNS neuroscience & therapeutics.
[16] T. Beresford,et al. Modafinil for the treatment of methamphetamine dependence. , 2012, Drug and alcohol dependence.
[17] S. Shoptaw,et al. Randomized trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use , 2014 .
[18] S. Shoptaw,et al. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. , 2014, Addiction.
[19] Marcel Zeelenberg,et al. Data analysis 2 , 2016 .